Literature DB >> 18803911

Use of stimulants to treat cocaine and methamphetamine abuse.

F Gerard Moeller1, Joy M Schmitz, David Herin, Kimberly L Kjome.   

Abstract

The concept of using stimulants to treat cocaine and methamphetamine dependence is largely based on the "replacement" therapy model that has shown efficacy for treating nicotine and opiate dependence. Although results have been mixed, some evidence supports using stimulant medication to reduce cocaine use. There are not enough data to date to determine the efficacy of stimulants for methamphetamine dependence. Drawbacks of stimulants as treatments include the potential for abuse of the treatment, which necessitates careful screening and monitoring of patients. Possible reasons for efficacy of stimulants include enhancement of monoamine function dysregulated by chronic cocaine or methamphetamine use. Newer medications that enhance dopamine function but lack the abuse potential of older stimulants are being studied. It is hoped that these medications will provide safe, effective treatment for cocaine and methamphetamine dependence, but more research on this topic is needed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18803911      PMCID: PMC9157609          DOI: 10.1007/s11920-008-0062-x

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   8.081


  31 in total

1.  Cognitive modeling analysis of decision-making processes in cocaine abusers.

Authors:  Julie C Stout; Jerome R Busemeyer; Anli Lin; Steven J Grant; Katherine R Bonson
Journal:  Psychon Bull Rev       Date:  2004-08

Review 2.  Drug addiction: the neurobiology of behaviour gone awry.

Authors:  Nora D Volkow; Ting-Kai Li
Journal:  Nat Rev Neurosci       Date:  2004-12       Impact factor: 34.870

3.  Evaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil.

Authors:  L H Gold; R L Balster
Journal:  Psychopharmacology (Berl)       Date:  1996-08       Impact factor: 4.530

4.  Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine.

Authors:  Diana Martinez; Rajesh Narendran; Richard W Foltin; Mark Slifstein; Dah-Ren Hwang; Allegra Broft; Yiyun Huang; Thomas B Cooper; Marian W Fischman; Herbert D Kleber; Marc Laruelle
Journal:  Am J Psychiatry       Date:  2007-04       Impact factor: 18.112

5.  Relationship between platelet serotonin uptake sites and measures of impulsivity, aggression, and craving among African-American cocaine abusers.

Authors:  Ashwin A Patkar; Edward Gottheil; Wade H Berrettini; Kevin P Hill; Charles C Thornton; Stephen P Weinstein
Journal:  Am J Addict       Date:  2003 Oct-Dec

6.  Efficacy of Adderall for Attention-Deficit/Hyperactivity Disorder: a meta-analysis.

Authors:  S V Faraone; J Biederman
Journal:  J Atten Disord       Date:  2002-09       Impact factor: 3.256

Review 7.  Approaches to the development of medications for the treatment of methamphetamine dependence.

Authors:  Frank J Vocci; Nathan M Appel
Journal:  Addiction       Date:  2007-04       Impact factor: 6.526

8.  Effects of chronic oral methylphenidate on cocaine self-administration and striatal dopamine D2 receptors in rodents.

Authors:  Panayotis K Thanos; Michael Michaelides; Helene Benveniste; Gene Jack Wang; Nora D Volkow
Journal:  Pharmacol Biochem Behav       Date:  2007-06-05       Impact factor: 3.533

9.  Cocaine dependence and d2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior.

Authors:  Diana Martinez; Allegra Broft; Richard W Foltin; Mark Slifstein; Dah-Ren Hwang; Yiyun Huang; Audrey Perez; W Gordon Frankle; Thomas Cooper; Herbert D Kleber; Marian W Fischman; Marc Laruelle; W Gordon Frankel
Journal:  Neuropsychopharmacology       Date:  2004-06       Impact factor: 7.853

10.  Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study.

Authors:  F R Levin; S M Evans; D M McDowell; H D Kleber
Journal:  J Clin Psychiatry       Date:  1998-06       Impact factor: 4.384

View more
  11 in total

1.  Rivastigmine reduces "Likely to use methamphetamine" in methamphetamine-dependent volunteers.

Authors:  R De La Garza; T F Newton; C N Haile; J H Yoon; C S Nerumalla; J J Mahoney; A Aziziyeh
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-12-30       Impact factor: 5.067

2.  Methamphetamine self-administration in humans during D-amphetamine maintenance.

Authors:  Erika Pike; William W Stoops; Lon R Hays; Paul E A Glaser; Craig R Rush
Journal:  J Clin Psychopharmacol       Date:  2014-12       Impact factor: 3.153

3.  Preclinical validation of a novel cocaine exposure therapy for relapse prevention.

Authors:  Claudia Mihindou; Caroline Vouillac; George F Koob; Serge H Ahmed
Journal:  Biol Psychiatry       Date:  2011-05-14       Impact factor: 13.382

4.  Evaluation of the dopamine β-hydroxylase (DβH) inhibitor nepicastat in participants who meet criteria for cocaine use disorder.

Authors:  Richard De La Garza; Marcy J Bubar; Crystal L Carbone; F Gerard Moeller; Thomas F Newton; Noelle C Anastasio; Tod A Harper; David L Ware; Michael A Fuller; Gaylyn J Holstein; Jason B Jayroe; Stephen I Bandak; Kirsten Z Reiman; Ann C Neale; Lesley B Pickford; Kathryn A Cunningham
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-01-17       Impact factor: 5.067

5.  Biological markers of the effects of intravenous methylphenidate on improving inhibitory control in cocaine-dependent patients.

Authors:  Chiang-Shan R Li; Peter T Morgan; David Matuskey; Osama Abdelghany; Xi Luo; Jeremy L K Chang; Bruce J Rounsaville; Yu-shin Ding; Robert T Malison
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

6.  Cardiovascular and Subjective Effects of the Novel Adenosine A(2A) Receptor Antagonist SYN115 in Cocaine Dependent Individuals.

Authors:  Sd Lane; Ce Green; Jl Steinberg; L Ma; Jm Schmitz; N Rathnayaka; Sd Bandak; S Ferre; Fg Moeller
Journal:  J Addict Res Ther       Date:  2012-03-28

Review 7.  Competing neurobehavioral decision systems theory of cocaine addiction: From mechanisms to therapeutic opportunities.

Authors:  Warren K Bickel; Sarah E Snider; Amanda J Quisenberry; Jeffrey S Stein; Colleen A Hanlon
Journal:  Prog Brain Res       Date:  2015-10-23       Impact factor: 2.453

8.  Methylphenidate remediates error-preceding activation of the default mode brain regions in cocaine-addicted individuals.

Authors:  David Matuskey; Xi Luo; Sheng Zhang; Peter T Morgan; Osama Abdelghany; Robert T Malison; Chiang-shan R Li
Journal:  Psychiatry Res       Date:  2013-08-23       Impact factor: 3.222

9.  Increased Orbitofrontal Brain Activation after Administration of a Selective Adenosine A(2A) Antagonist in Cocaine Dependent Subjects.

Authors:  F Gerard Moeller; Joel L Steinberg; Scott D Lane; Kimberly L Kjome; Liangsuo Ma; Sergi Ferre; Joy M Schmitz; Charles E Green; Stephen I Bandak; Perry F Renshaw; Larry A Kramer; Ponnada A Narayana
Journal:  Front Psychiatry       Date:  2012-05-28       Impact factor: 4.157

10.  Combination of Modafinil and d-amphetamine for the Treatment of Cocaine Dependence: A Preliminary Investigation.

Authors:  Joy M Schmitz; Nuvan Rathnayaka; Charles E Green; F Gerard Moeller; Anne E Dougherty; John Grabowski
Journal:  Front Psychiatry       Date:  2012-08-30       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.